Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Prehabilitation during neoadjuvant chemotherapy in advanced ovarian cancer is associated with improved surgical candidacy and chemotherapy outcomes.
Journal: Gynecologic oncology
Published: May 05, 2026
Long-Term Survival in High-Grade Serous Ovarian Cancer Compared With the General US Population: A 30-Year Landmark Analysis.
Journal: JCO oncology advances
Published: April 01, 2026
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.
Journal: Research square
Published: November 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.
Journal: medRxiv : the preprint server for health sciences
Published: October 03, 2025
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.
Journal: Nature communications
Published: September 22, 2025
A Phase 2 Trial of Protein Kinase C Iota Inhibition With the Combination of Auranofin and Sirolimus in Patients With Recurrent Ovarian Cancer.
Journal: American journal of clinical oncology
Published: September 08, 2025
Clinical effectiveness of best-evidence cancer distress management in a real-world practice setting.
Clinical effectiveness of best-evidence cancer distress management in a real-world practice setting.
Journal: Translational behavioral medicine
Published: June 27, 2025
Multi-center, international endometrial cancer consortium highlights.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: March 24, 2025
Assessing the Current Stage of Burnout in Hematology-Oncology Faculty and Trainees- Is There a Path to Remission?
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 08, 2025
Pembrolizumab and epigenetic modification with azacitidine reshapes the tumor microenvironment of platinum-resistant epithelial ovarian cancer: a phase 2 non-randomized clinical trial.
Journal: Communications medicine
Published: December 28, 2024
Phase II study of the efficacy and safety of palbociclib in patients with recurrent ovarian cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: December 16, 2024
Metformin for patients with advanced stage ovarian cancer: A randomized phase II placebo-controlled trial.
Journal: Gynecologic oncology
Published: October 08, 2024
Last Updated: 09/26/2026